T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.85% |
| 2 | Technology | 18.49% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 14.06% |
| 5 | Communication Services | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Ternium
TX
$10.7B
| $5.07M | ﹤0.01% |
187,246
-117,902
| -39% | -$3.51M |
|
1402
Cactus
WHD
$5.88B
| $5.07M | ﹤0.01% |
+184,874
| New | +$6.05M |
|
|
SMC
1403
Summit Midstream
SMC
$475M
| $5.03M | ﹤0.01% |
33,333
| – | – |
|
|
NFX
1404
DELISTED
Newfield Exploration
NFX
| $5M | ﹤0.01% |
341,006
| – | – |
|
1405
Star Group
SGU
$415M
| $4.87M | ﹤0.01% |
521,326
-217,907
| -29% | -$2.1M |
|
1406
Wolfspeed
WOLF
$1.6B
| $4.86M | ﹤0.01% |
113,701
-632,086
| -85% | -$25.6M |
|
1407
Targa Resources
TRGP
$58.5B
| $4.79M | ﹤0.01% |
133,079
-308,198
| -70% | -$14.9M |
|
1408
Wheaton Precious Metals
WPM
$61B
| $4.5M | ﹤0.01% |
230,578
-509
| -0.2% | -$8.68K |
|
1409
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $4.46M | ﹤0.01% |
55,000
| – | – |
|
1410
United Therapeutics
UTHR
$21.3B
| $4.45M | ﹤0.01% |
40,841
+125
| +0.3% | +$14.5K |
|
1411
Gaming and Leisure Properties
GLPI
$12.7B
| $4.44M | ﹤0.01% |
137,429
+21,197
| +18% | +$717K |
|
1412
W.P. Carey
WPC
$16.3B
| $4.43M | ﹤0.01% |
69,245
+16,233
| +31% | +$1.06M |
|
1413
Badger Meter
BMI
$3.77B
| $4.43M | ﹤0.01% |
89,977
-47,196
| -34% | -$2.42M |
|
|
ASRT
1414
DELISTED
Assertio
ASRT
| $4.39M | ﹤0.01% |
20,285
-148
| -0.7% | -$44.4K |
|
1415
Louisiana-Pacific
LPX
$5.17B
| $4.34M | ﹤0.01% |
195,560
+6,590
| +3% | +$149K |
|
1416
Larimar Therapeutics
LRMR
$437M
| $4.31M | ﹤0.01% |
72,560
-31,147
| -30% | -$3.07M |
|
|
MRUS
1417
DELISTED
Merus
MRUS
| $4.28M | ﹤0.01% |
305,816
-400
| -0.1% | -$5.79K |
|
|
TC
1418
TuanChe
TC
$51.8M
| $4.26M | ﹤0.01% |
+527
| New | +$4.46M |
|
|
HAPN
1419
Happen Inc
HAPN
$2.27B
| $4.26M | ﹤0.01% |
323,743
-48,246
| -13% | -$796K |
|
|
FDC
1420
DELISTED
First Data Corporation
FDC
| $4.19M | ﹤0.01% |
247,676
+46,482
| +23% | +$906K |
|
1421
Arcus Biosciences
RCUS
$3.59B
| $4.17M | ﹤0.01% |
387,312
-1,078
| -0.3% | -$12.6K |
|
1422
Snap
SNAP
$9.23B
| $4.13M | ﹤0.01% |
749,578
-124,412
| -14% | -$809K |
|
|
TCO
1423
DELISTED
Taubman Centers Inc.
TCO
| $4.13M | ﹤0.01% |
90,768
-129,997
| -59% | -$6.82M |
|
1424
Acuity Brands
AYI
$10.8B
| $4M | ﹤0.01% |
34,823
-188,433
| -84% | -$23.3M |
|
|
ITCI
1425
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4M | ﹤0.01% |
350,963
-90,215
| -20% | -$1.46M |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.